In the last few years, several publications suggest involvement of the Angpt/Tek system in several diseases with endothelial dysfunction including diabetes, sepsis, cancer, malaria and fibrosis, and increased ANGPT2/ANGPT1 levels appear to be associated with adverse outcomes [14–24]. This evidence concerns the gene ANGPT1 and diabetes mellitus.